Business Segment Information (Tables)

6 Months Ended

Jun. 28, 2025

2025


	Three months ended June 28, 2025
(In millions)	Life Sciences Solutions		Analytical Instruments		Specialty Diagnostics		Laboratory Products and Biopharma Services		Total
Revenues
Revenues from external customers	$	2,115	$	1,669	$	1,118	$	5,953	$	10,855
Intersegment revenues	385		58		16		42		501
	2,499		1,728		1,134		5,995		11,356
Elimination of intersegment revenues									(501)
Consolidated revenues									$	10,855
Segment Income
Cost of revenues	925		902		640		4,683
Selling, general, and administrative expenses	467		318		183		599
Research and development expenses	136		145		47		14
Other segment items	53		37		(42)		(126)
Segment income	919		325		306		825		2,375
Unallocated amounts
Cost of revenues adjustments									(10)
Selling, general and administrative expenses adjustments									(20)
Restructuring and other costs									(82)
Amortization of acquisition-related intangible assets									(429)
Interest income									297
Interest expense									(404)
Other income/(expense)									(19)
Consolidated income before income taxes									$	1,709


(In millions)	Unallocated amounts		Life Sciences Solutions		Analytical Instruments		Specialty Diagnostics		Laboratory Products and Biopharma Services		Consolidated
Segment assets	$	87,013	$	3,142	$	3,070	$	1,295	$	6,711	$	101,230
Purchases of property, plant and equipment	25		25		13		25		206		294
Depreciation of property, plant and equipment	—		56		26		23		152		256

2024


	Three months ended June 29, 2024
(In millions)	Life Sciences Solutions		Analytical Instruments		Specialty Diagnostics		Laboratory Products and Biopharma Services		Total
Revenues
Revenues from external customers	$	1,996	$	1,727	$	1,100	$	5,719	$	10,541
Intersegment revenues	359		55		17		39		470
	2,355		1,782		1,117		5,758		11,011
Elimination of intersegment revenues									(470)
Consolidated revenues									$	10,541
Segment Income
Cost of revenues	860		852		623		4,504
Selling, general, and administrative expenses	428		305		188		596
Research and development expenses	130		139		44		17
Other segment items	73		47		(37)		(104)
Segment income	865		439		299		745		2,347
Unallocated amounts
Cost of revenues adjustments									(1)
Selling, general and administrative expenses adjustments									64
Restructuring and other costs									(77)
Amortization of acquisition-related intangible assets									(513)
Interest income									295
Interest expense									(354)
Other income/(expense)									5
Consolidated income before income taxes									$	1,765


(In millions)	Unallocated amounts		Life Sciences Solutions		Analytical Instruments		Specialty Diagnostics		Laboratory Products and Biopharma Services		Consolidated
Segment assets	$	85,247	$	3,025	$	2,723	$	1,188	$	6,314	$	98,496
Purchases of property, plant and equipment	15		26		18		21		220		301
Depreciation of property, plant and equipment	—		57		25		22		173		276

2025


	Six months ended June 28, 2025
(In millions)	Life Sciences Solutions		Analytical Instruments		Specialty Diagnostics		Laboratory Products and Biopharma Services		Total
Revenues
Revenues from external customers	$	4,069	$	3,346	$	2,248	$	11,556	$	21,219
Intersegment revenues	771		99		34		79		983
	4,840		3,446		2,282		11,635		22,202
Elimination of intersegment revenues									(983)
Consolidated revenues									$	21,219
Segment Income
Cost of revenues	1,781		1,738		1,319		9,107
Selling, general, and administrative expenses	936		633		354		1,191
Research and development expenses	273		282		92		27
Other segment items	97		69		(93)		(246)
Segment income	1,753		724		610		1,557		4,644
Unallocated amounts
Cost of revenues adjustments									(21)
Selling, general and administrative expenses adjustments									(34)
Restructuring and other costs									(180)
Amortization of acquisition-related intangible assets									(859)
Interest income									501
Interest expense									(707)
Other income/(expense)									(16)
Consolidated income before income taxes									$	3,329


(In millions)	Unallocated amounts		Life Sciences Solutions		Analytical Instruments		Specialty Diagnostics		Laboratory Products and Biopharma Services		Consolidated
Segment assets	$	87,013	$	3,142	$	3,070	$	1,295	$	6,711	$	101,230
Purchases of property, plant and equipment	61		69		57		58		412		656
Depreciation of property, plant and equipment	—		114		50		44		324		532

2024


	Six months ended June 29, 2024
(In millions)	Life Sciences Solutions		Analytical Instruments		Specialty Diagnostics		Laboratory Products and Biopharma Services		Total
Revenues
Revenues from external customers	$	3,926	$	3,356	$	2,200	$	11,404	$	20,886
Intersegment revenues	714		113		27		76		930
	4,640		3,469		2,227		11,480		21,817
Elimination of intersegment revenues									(930)
Consolidated revenues									$	20,886
Segment Income
Cost of revenues	1,680		1,651		1,251		9,004
Selling, general, and administrative expenses	859		623		375		1,181
Research and development expenses	262		270		84		34
Other segment items	133		86		(76)		(228)
Segment income	1,705		838		593		1,489		4,625
Unallocated amounts
Cost of revenues adjustments									(17)
Selling, general and administrative expenses adjustments									45
Restructuring and other costs									(106)
Amortization of acquisition-related intangible assets									(1,065)
Interest income									574
Interest expense									(717)
Other income/(expense)									14
Consolidated income before income taxes									$	3,354


(In millions)	Unallocated amounts		Life Sciences Solutions		Analytical Instruments		Specialty Diagnostics		Laboratory Products and Biopharma Services		Consolidated
Segment assets	$	85,247	$	3,025	$	2,723	$	1,188	$	6,314	$	98,496
Purchases of property, plant and equipment	38		51		46		53		460		648
Depreciation of property, plant and equipment	—		112		50		44		356		562